Page last updated: 2024-08-26

yttrium radioisotopes and Cerebral Hemorrhage

yttrium radioisotopes has been researched along with Cerebral Hemorrhage in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hess, G; Huglo, D; Illidge, T; Kalmus, J; Liberati, AM; Marcus, R; Martinelli, G; Milpied, N; Morschhauser, F; Paganelli, G; Rule, S; Stein, H; Zinzani, PL	1

Trials

1 trial(s) available for yttrium radioisotopes and Cerebral Hemorrhage

Article	Year
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation. Blood, 2007, Jul-01, Volume: 110, Issue:1 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes	2007

Article

Year

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.

Blood, 2007, Jul-01, Volume: 110, Issue:1

Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes

2007